(Q34767647)

English

A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

6 references

19 March 2019

24 March 2019

20 August 2019

28 September 2019

2 October 2019

20 January 2021

A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control (English)

1 reference

Europe PubMed Central

4 August 2017

Phaseolus vulgaris

0 references

5 references

19 March 2019

24 March 2019

20 August 2019

28 September 2019

2 October 2019

physiological phenomenon

1 reference

20 August 2019

1 reference

28 September 2019

mechanism of action

1 reference

2 October 2019

enzyme inhibitor

1 reference

20 January 2021

author name string

Marilyn L Barrett

1

1 reference

Europe PubMed Central

4 August 2017

Jay K Udani

2

1 reference

Europe PubMed Central

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 March 2011

7 references

Europe PubMed Central

4 August 2017

19 March 2019

24 March 2019

20 August 2019

28 September 2019

2 October 2019

20 January 2021

Nutrition Journal

7 references

Europe PubMed Central

4 August 2017

19 March 2019

24 March 2019

20 August 2019

28 September 2019

2 October 2019

20 January 2021

10

1 reference

Europe PubMed Central

4 August 2017

24

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

6 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

20 August 2019

Europe PubMed Central

28 September 2019

Europe PubMed Central

2 October 2019

Europe PubMed Central

20 January 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1475-2891-10-24

0 references

US biosimilar pathway unlikely to be used: developers will opt for a traditional BLA filing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Dietary glycemic index: health implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Lowering the glycemic index of white bread using a white bean extract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Biosimilar therapeutics-what do we need to consider?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Metabolic effects of low glycaemic index diets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Low-digestible carbohydrates in practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Low glycaemic index or low glycaemic load diets for overweight and obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

The inhibitory effects of berry polyphenols on digestive enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Carbohydrate bioavailability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Resistant starch: metabolic effects and potential health benefits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Lactose malabsorption. Optimalization of investigational methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

Impairment of starch absorption by a potent amylase inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

7 July 2018

Evaluation of different teas against starch digestibility by mammalian glycosidases

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

Characterization of alpha-Amylase-Inhibitor, a Lectin-Like Protein in the Seeds of Phaseolus vulgaris.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) extract in rats.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071778

26 October 2018

Fiber and Magnesium Intake and Incidence of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-10-24

21 January 2018

Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary assessment of the acute and subchronic toxicity profile of phase2: an alpha-amylase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal and metabolic effects of amylase inhibition in diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1475-2891-10-24

1 reference

Europe PubMed Central

4 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34767647&oldid=1947123454"